These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38050273)

  • 1. Full thermal ablation versus partial thermal ablation for secondary hyperparathyroidism: A meta-analysis.
    Gong L; Liu X; Yang Q; Jiang W; Liu X; Li X; Xu W
    Medicine (Baltimore); 2023 Dec; 102(48):e36422. PubMed ID: 38050273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
    Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
    Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A meta-analysis.
    Gong L; Tang W; Lu J; Xu W
    Int J Surg; 2019 Oct; 70():13-18. PubMed ID: 31404676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided microwave ablation for secondary hyperparathyroidism: a systematic review and meta-analysis.
    Zhou X; Shen Y; Zhu Y; Lv Q; Pu W; Gao L; Gu M; Li C
    Int J Hyperthermia; 2021; 38(1):1285-1294. PubMed ID: 34428994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis.
    Cao XJ; Zhao ZL; Wei Y; Peng LL; Li Y; Yu MA
    Int J Hyperthermia; 2020; 37(1):316-323. PubMed ID: 32253954
    [No Abstract]   [Full Text] [Related]  

  • 6. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials.
    Xu J; Yang Y; Ma L; Fu P; Peng H
    Int Urol Nephrol; 2019 Nov; 51(11):2027-2036. PubMed ID: 31531805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study.
    Li X; Wei Y; Shao H; Peng L; An C; Yu MA
    Int J Hyperthermia; 2019; 36(1):647-653. PubMed ID: 31305184
    [No Abstract]   [Full Text] [Related]  

  • 9. A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.
    Zhao S; Gan W; Xie W; Cao J; Zhang L; Wen P; Yang J; Xiong M
    Ren Fail; 2022 Dec; 44(1):23-29. PubMed ID: 35094636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.
    Zeng Z; Peng CZ; Liu JB; Li YW; He HF; Hu QH; Lin B; Shen XG
    Sci Rep; 2020 Apr; 10(1):6206. PubMed ID: 32277134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation.
    Yue W; Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Xu D; Peng C
    Int J Hyperthermia; 2023; 40(1):2223370. PubMed ID: 37344379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
    Qiu X; Gao M; Zhang D; Ji F
    Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis.
    Gao D; Lou Y; Cui Y; Liu S; Cui W; Sun G
    Ren Fail; 2022 Dec; 44(1):503-512. PubMed ID: 35285377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
    Liu Y; Yang Q; Chen G; Zhou T
    Curr Pharm Des; 2022; 28(40):3289-3304. PubMed ID: 36305135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism.
    Ma H; Ouyang C; Huang Y; Xing C; Cheng C; Liu W; Yuan D; Zeng M; Yu X; Ren H; Yuan Y; Zhang L; Xu F; Cui Y; Ren W; Huang H; Qian H; Fan B; Wang N
    Ren Fail; 2020 Nov; 42(1):66-76. PubMed ID: 31928297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation].
    Bo SJ; Xu XF; Qiu CY; Wang TT; Ning YD; Li HY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(2):142-147. PubMed ID: 29757564
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study.
    Yu MA; Yao L; Zhang L; Peng L; Zhuo L; Zhang Y; Li W; Lv MD
    Int J Hyperthermia; 2016; 32(2):180-6. PubMed ID: 26606889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study.
    Chen CC; Chen HL; Chiang PL; Luo SD; Chang YH; Chen WC; Wang CK; Lin AN; Chen YS; Chi SY; Lin WC
    Int J Hyperthermia; 2022; 39(1):907-917. PubMed ID: 35848429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.
    Yue W; Jiang T; Ai Z; Deng E; Chai H; Li X; He H; Zhang Z; Weng N; Qin X; Fan J; Tang X; Heng W; Li Y; Sun L; Peng C; Xu H
    Radiology; 2024 Apr; 311(1):e231852. PubMed ID: 38625007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis.
    Xu W; Gong L; Lu J; Tang W
    Exp Ther Med; 2020 Oct; 20(4):3237-3243. PubMed ID: 32855693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.